Skip to content
Psilocybin Technology
Menu
  • Home
  • Contact us about Psilocybin Science and Technology

Month: April 2018

Anxiety / Microdosing / Mushrooms / Psilocybin / Psilocybin Chemistry / Research / State of the Art / Treatment / Unmet Need

Psilocybin Formulations for Treating Anxiety

Psilocybin Formulations for Treating Anxiety Many people suffering from anxiety would benefit from access to psilocybin.  Anecdotal reports suggest that it could be a safe and effective option for treating …

Uncategorized

PROBLEM SOLVED: Why no DMT in Magic Mushrooms?

Read this article at Psychedelic Science Review

Mushrooms / Psilocybin / Research / Treatment

Psilocybin Formulations for Treating Cluster Headaches

Psilocybin Formulations for Treating Cluster Headaches Many people suffering from cluster headaches could benefit from access to psilocybin as a treatment option. Today, a small population of cluster headache sufferers …

Cognitive Enhancement / Depression / Microdosing / Psilocybin / State of the Art / Treatment / Unmet Need

Psilocybin for Improving Athletic Performance

Psilocybin for Improving Athletic Performance Can psilocybin be taken to improve athletic performance? Yes, probably. Psilocybin and other “psychedelics” have earned new fame as cognitive enhancers when taken in “sub-threshold” doses, …

Microdosing / Mushrooms / Psilocybin / State of the Art

Psilocybin Microdosing – State of the Art

Psilocybin “Microdosing” State of the Art — Unknown Molecules & Lack of Precise Dosing Our staff recently published a few articles regarding “microdosing,” especially microdosing psilocybin.  We have received many …

Anxiety / Cognitive Enhancement / Microdosing / Psilocybin Chemistry / State of the Art / Treatment / Unmet Need

Needed Improvements in “Microdosing” Education

Simple Improvements in Microdosing Education For a variety of excellent reasons, many people are ingesting psilocybin (and “drugs” like LSD and cannabis) in amounts that don’t cause hallucinations. Taking therapeutic …

Uncategorized

Norbaeocystin – An Active Component in Magic Mushrooms?

Read this article at Psychedelic Science Review

Recent Posts

  • Nova Mentis Launches Entourage Effect Research
  • Graham Pechenik and Noah Potter discuss Psychedelic Patents
  • MindMed – Two Steps Closer to Next Generation Magic Mushroom Formulations
  • COMPASS Pathways’ $100+ Million Crystalline Form Patent
  • MagicMed – The First Psychedelic Patent Troll?

Recent Comments

  • Psilocybin Expert on Taking Pure Psilocybin is Different from Eating Magic Mushrooms
  • jim on Cannabis and Magic Mushrooms – A Near Perfect Analogy
  • jeff on China Enters Magic Mushroom Industry – Wuhan, MJMedTech, and M2BIO
  • jeff on Chemical & Engineering News Discusses Entourage Effect
  • jeff on Psilocybin Clinical Trials Approved by FDA

Archives

  • January 2021
  • November 2020
  • September 2020
  • July 2020
  • February 2020
  • January 2020
  • December 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • November 2017
  • October 2017

Categories

  • Aeruginascin
  • Anxiety
  • Business
  • Cognitive Enhancement
  • Decriminalization
  • Depression
  • Law
  • Legalization
  • Mass
  • Microdosing
  • Molecules vs. Mushrooms
  • Mushrooms
  • Patents
  • Psilocin
  • Psilocybin
  • Psilocybin Chemistry
  • Psilocybin Derivatives
  • Psilocybin Science
  • Research
  • State of the Art
  • Treatment
  • Uncategorized
  • Unmet Need
  • Wood Lover Paralysis

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Copyright © 2021 Psilocybin Technology – OnePress theme by FameThemes